Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in patients with dyspepsia in a GI clinic: A 7-year cross-sectional study

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Khademi, Hooman ^a,b   Radmard, Amir Reza ^a   Malekzadeh, Fatemeh ^a   Kamangar, Farin ^a,c   Nasseri Moghaddam, Siavosh ^a   Johansson, Mattias ^b   Byrnes, Graham ^b   Brennan, Paul ^b   Malekzadeh, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c MORGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DUODENUM CANCER; DYSPEPSIA; DYSPHAGIA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS CANCER; FAMILY HISTORY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IRAN; LOGISTIC REGRESSION ANALYSIS; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PREDICTION; PREDICTIVE VALUE; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STOMACH CANCER; VOMITING; WEIGHT REDUCTION;

ADULT; CROSS-SECTIONAL STUDIES; DYSPEPSIA; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 84862238104     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039173     Document Type: Article

References (64)

1. Barbara L, Camilleri M, Corinaldesi R, Crean GP, Heading RC, et al. (1989) Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci 34: 1272-1276.
2. Talley NJ, Vakil NB, Moayyedi P, (2005) American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 129: 1756-1780.
3. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, et al. (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122: 1500-1511.
4. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ 3rd, (1992) Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 102: 1259-1268.
5. El-Serag HB, Talley NJ, (2004) Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 19: 643-654.
6. Moayyedi P, Mason J, (2002) Clinical and economic consequences of dyspepsia in the community. Gut 50: iv10-12.
7. Heikkinen M, Pikkarainen P, Takala J, Rasanen H, Julkunen R, (1995) Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 30: 519-523.
8. Ayoola EA, al-Rashed RS, al-Mofleh IA, al-Faleh FZ, Laajam M, (1996) Diagnostic yield of upper gastrointestinal endoscopy in relation to age and gender: a study of 10112 Saudi patients. Hepatogastroenterology 43: 409-415.
9. Mansi C, Mela GS, Pasini D, Grosso M, Corti L, et al. (1990) Patterns of dyspepsia in patients with no clinical evidence of organic diseases. Dig Dis Sci 35: 1452-1458.
10. Talley NJ, (1993) Nonulcer dyspepsia: current approaches to diagnosis and management. Am Fam Physician 47: 1407-1416.
11. Bazaldua OV, Schneider FD, (1999) Evaluation and management of dyspepsia. Am Fam Physician 60: 1773-1784, 1787-1778.
12. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, et al. (1998) AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 114: 582-595.
13. Fisher RS, Parkman HP, (1998) Management of nonulcer dyspepsia. N Engl J Med 339: 1376-1381.
14. Bytzer P, Talley NJ, (2001) Dyspepsia. Ann Intern Med 134: 815-822.
15. Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, et al. (2003) The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 17: 1481-1491.
16. Moayyedi P, Axon AT, (1999) The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am J Gastroenterol 94: 3122-3125.
17. Delaney B, Ford AC, Forman D, Moayyedi P, Qume M, (2005) Initial management strategies for dyspepsia. Cochrane Database Syst Rev.
18. Ford AC, Moayyedi P, (2008) Current guidelines for dyspepsia management. Dig Dis 26: 225-230.
19. Talley NJ, Vakil N, (2005) Guidelines for the management of dyspepsia. Am J Gastroenterol 100: 2324-2337.
20. (2004) National Institute for Health and Clinical Excellence. Dyspepsia: Managing dyspepsia in adults in primary care.
21. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, et al. (2002) Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16: 167-180.
22. Barkun A, Crott R, Fallone C, Kennedy W, Lachaine J, et al. (2010) A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care. Can J Gastroenterol 24: 489-498.
23. Vakil N, Talley N, van Zanten SV, Flook N, Persson T, et al. (2009) Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol 7: 756-761.
24. Parkin DM, Bray FI, Devesa SS, (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37: S4-66.
25. Eisen GM, Dominitz JA, Faigel DO, Goldstein JA, Kalloo AN, et al. (2001) The role of endoscopy in dyspepsia. Gastrointest Endosc 54: 815-817.
26. van Zanten SJOV, Flook N, Chiba N, Armstrong D, Barkun A, et al. (2000) An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Medical Association Journal 162: S3-S23.
27. (1998) American Gastroenterological Association medical position statement: Evaluation of dyspepsia. Gastroenterology 114: 579-581.
28. Kapoor N, Bassi A, Sturgess R, Bodger K, (2005) Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. Gut 54: 40-45.
29. Wallace MB, Durkalski VL, Vaughan J, Palesch YY, Libby ED, et al. (2001) Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut 49: 29-34.
30. Vakil N, Moayyedi P, Fennerty MB, Talley NJ, (2006) Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology 131: 390-401; quiz 659-360.
31. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ, (2004) Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut 53: 666-672.
32. Voutilainen M, Mantynen T, Mauranen K, Kunnamo I, Juhola M, (2005) Is it possible to reduce endoscopy workload using age, alarm symptoms and H. pylori as predictors of peptic ulcer and oesophagogastric cancers? Dig Liver Dis 37: 526-532.
33. Fransen GA, Janssen MJ, Muris JW, Laheij RJ, Jansen JB, (2004) Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy. Aliment Pharmacol Ther 20: 1045-1052.
34. Dickerson LM, King DE, (2004) Evaluation and management of nonulcer dyspepsia. Am Fam Physician 70: 107-114.
35. Axon AT, Bell GD, Jones RH, Quine MA, McCloy RF, (1995) Guidelines on appropriate indications for upper gastrointestinal endoscopy. Working Party of the Joint Committee of the Royal College of Physicians of London, Royal College of Surgeons of England, Royal College of Anaesthetists, Association of Surgeons, the British Society of Gastroenterology, and the Thoracic Society of Great Britain. BMJ 310: 853-856.
36. Hallissey MT, Allum WH, Jewkes AJ, Ellis DJ, Fielding JW, (1990) Early detection of gastric cancer. BMJ 301: 513-515.
37. Delaney BC, Wilson S, Roalfe A, Roberts L, Redman V, et al. (2000) Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. Lancet 356: 1965-1969.
38. Ford AC, Axon AT, (2010) Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 15: 1-6.
39. Babaei M, Pourfarzi F, Yazdanbod A, Chiniforush MM, Derakhshan MH, et al. (2010) Gastric cancer in Ardabil, Iran-a review and update on cancer registry data. Asian Pac J Cancer Prev 11: 595-599.
40. Malekzadeh R, Derakhshan MH, Malekzadeh Z, (2009) Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med 12: 576-583.
41. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H, (2010) Five common cancers in Iran. Arch Iran Med 13: 143-146.
42. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, et al. (2005) Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev 6: 359-363.
43. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M, (2009) Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med 12: 15-23.
44. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, et al. (2004) Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol 57: 37-42.
45. Derakhshan MH, Yazdanbod A, Sadjadi AR, Shokoohi B, McColl KE, et al. (2004) High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut 53: 1262-1266.
46. Barazandeh F, Yazdanbod A, Pourfarzi F, Ghajarieh Sepanlou S, Derakhshan MH, et al. (2012) Epidemiology of Peptic Ulcer Disease: Endoscopic Results of a Systematic Investigation in Iran. Middle East Journal of Digestive Disease 4: 90-96.
47. Spechler SJ, (1999) AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology 117: 233-254.
48. Schroeder BM, (2003) Evaluation of epigastric discomfort and management of dyspepsia and GERD. Am Fam Physician 68: 1215-1216, 1219-1220.
49. Bramble MG, Suvakovic Z, Hungin AP, (2000) Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 46: 464-467.
50. Deeks JJ, Altman DG, (2004) Diagnostic tests 4: likelihood ratios. BMJ 329: 168-169.
51. Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KG, (2003) Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 56: 441-447.
52. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, et al. (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54: 774-781.
53. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, et al. (2010) Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21: 128-138.
54. Grund B, Sabin C, (2010) Analysis of biomarker data: logs, odds ratios, and receiver operating characteristic curves. Curr Opin HIV AIDS 5: 473-479.
55. Vickers AJ, Cronin AM, Begg CB, (2011) One statistical test is sufficient for assessing new predictive markers. BMC Med Res Methodol 11: 13.
56. Cook NR, (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115: 928-935.
57. Cook NR, (2008) Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 54: 17-23.
58. Pencina MJ, D'Agostino RB, Vasan RS, (2010) Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med 48: 1703-1711.
59. Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, et al. (1996) The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 111: 85-92.
60. Numans ME, van der Graaf Y, de Wit NJ, de Melker RA, (2001) How useful is selection based on alarm symptoms in requesting gastroscopy? An evaluation of diagnostic determinants for gastro-oesophageal malignancy. Scand J Gastroenterol 36: 437-443.
61. Bai Y, Li ZS, Zou DW, Wu RP, Yao YZ, et al. (2010) Alarm features and age for predicting upper gastrointestinal malignancy in Chinese patients with dyspepsia with high background prevalence of Helicobacter pylori infection and upper gastrointestinal malignancy: an endoscopic database review of 102,665 patients from 1996 to 2006. Gut 59: 722-728.
62. Nasseri-Moghaddam S, Razjouyan H, Alimohamadi SM, Mamarabadi M, Ghotbi MH, et al. (2007) Prospective Acid Reflux Study of Iran (PARSI): methodology and study design. BMC Gastroenterol 7: 42.
63. Chen LQ, Hu CY, Ghadirian P, Duranceau A, (1999) Early detection of esophageal squamous cell carcinoma and its effects on therapy: an overview. Dis Esophagus 12: 161-167.
64. Ford AC, Qume M, Moayyedi P, Arents NL, Lassen AT, et al. (2005) Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology 128: 1838-1844.